About the Drug-Induced Skin Reactions Session
Drug-induced skin reactions are adverse effects resulting from medications, manifesting as various dermatological conditions. Common reactions include rashes, urticaria (hives), and photosensitivity, which can occur shortly after starting a new medication or even after prolonged use. The severity of these reactions can range from mild irritation to life-threatening conditions like Stevens-Johnson syndrome. Identification of the offending drug is crucial for effective management, often involving withdrawal of the medication and symptomatic treatment. Dermatologists play a key role in diagnosing these reactions, using clinical history and sometimes patch testing. Understanding drug-induced skin reactions is essential for safe prescribing practices and patient education in both dermatology and cosmetology, as some treatments may exacerbate existing sensitivities.
Featured Speakers — Drug-Induced Skin Reactions 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Drug-Induced Skin Reactions Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Drug-Induced Skin Reactions Conference 2027
Present Your Research
Oral and poster slots for original Drug-Induced Skin Reactions work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Drug-Induced Skin Reactions research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Drug-Induced Skin Reactions track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Drug-Induced Skin Reactions Conference 2027 — FAQs
What is the Drug-Induced Skin Reactions track at IDC 2027?
The Drug-Induced Skin Reactions track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Drug-Induced Skin Reactions. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Drug-Induced Skin Reactions sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Drug-Induced Skin Reactions are all welcome — whether presenting or attending.
Can I present my research in the Drug-Induced Skin Reactions track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Drug-Induced Skin Reactions sessions?
Yes. IDC 2027 is a hybrid conference — attend the Drug-Induced Skin Reactions track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.